Similarly, there was no difference in the levels of circulating CD15+ cells within the CD33+CD11b+HLA-DR−/low populations (HD; 67.1 ± 2.1 vs PBC; 68.5 ± 3.0, Fig. 2e). This evidence concerns the gene CD33 and primary biliary cholangitis.